stock outlook

TeraWulf (WULF) Stock Today: Price Action, AI Data Center Deals, and Outlook for November 24, 2025

TeraWulf Inc. (NASDAQ: WULF) — a Bitcoin miner turned high‑performance computing (HPC) and AI data center operator — continues to trade with extreme volatility as investors digest a “transformational” third quarter, massive new contracts, and aggressive financing moves. As of

24 November 2025

Sonder Holdings (SOND) Bankruptcy Latest: Chapter 7 Liquidation, Lawsuits and Stock Outlook – 20 November 2025

Sonder Holdings Inc. (NASDAQ: SOND) is now in full collapse mode. After Marriott International abruptly terminated a 20‑year licensing agreement on 9 November, Sonder announced on 10 November that it would immediately wind down operations and pursue a Chapter 7

20 November 2025

Bankruptcy · Company Analysis · Financial Updates · Legal News · NASDAQ:SOND · NYSE:MAR · Stock Market

Woodside Energy (ASX: WDS) Stock Outlook: What to Know Before the ASX Opens on 17 November 2025

Woodside Energy Group Ltd (ASX: WDS, NYSE: WDS) heads into Monday’s trade with its share price near recent highs, a strong growth story in LNG, but also rising political, legal and ESG pressure at home and abroad. Here’s what traders

16 November 2025

ASX Updates · Energy Sector · Financial News · Investing · Stock Market

Telstra (ASX: TLS) Stock Outlook: What to Know Before the ASX Opens on 17 November 2025

As the Australian share market prepares to open on Monday, 17 November 2025, Telstra Group Limited (still commonly referred to as Telstra Corporation Limited and trading under the ticker ASX: TLS) will be on a lot of watchlists. The Telstra

16 November 2025

ASX News · Investment Tips · Market Outlook · Stock Market · Telstra

Applied Materials (AMAT) Stock Slides as China Export Curbs Cloud Outlook Despite Q4 2025 Earnings Beat

Applied Materials (NASDAQ: AMAT) beat fiscal Q4 2025 earnings expectations, but AMAT stock fell around 5–7% on November 14 as U.S. export controls and weaker China spending weighed on the 2026 outlook. Key takeaways Q4 2025: Earnings beat and record

14 November 2025

China Market · Earnings · Export Regulations · NASDAQ:AMAT · Semiconductors · Stock Analysis

Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Below we dive into a detailed analysis of RXRX – covering the latest developments, the company’s AI-powered business model, financials, key partnerships, expert commentary, technical trends, forecasts, and how Recursion compares to other AI-focused biotech players. Latest Developments and News

5 November 2025

AI in Healthcare · Biotechnology · Drug Discovery · Executive Leadership · NASDAQ:RXRX · Stock Market Analysis